Tumor Biology

, Volume 35, Issue 1, pp 785–790 | Cite as

RETRACTED ARTICLE: Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis

  • Shayang Luo
  • Lei Guo
  • Yan Li
  • Shouman Wang
Research Article


Vitamin D receptor (VDR) principally mediates the anticancer activities of vitamin D. Many studies investigated the association between VDR gene ApaI polymorphism and breast cancer, but the results were inconclusive. We performed this meta-analysis to evaluate the association between VDR gene ApaI polymorphism and breast cancer. Twelve studies with a total of 8,254 subjects were identified from PubMed and Wanfang databases. The pooled odds ratio (OR) and confidence intervals (95 % CI) were used to assess the association. The meta-analysis indicated that VDR gene ApaI polymorphism was not associated with risk of breast cancer (a vs. A: OR = 0.97, 95 % CI 0.91–1.04, P = 0.378; aa vs. AA: OR = 0.97, 95 % CI 0.85–1.10, P = 0.618; aa vs. AA + Aa: OR = 1.00, 95 % CI 0.89–1.12, P = 0.972; aa + Aa vs. AA: OR = 0.95, 95 % CI 0.82–1.11, P = 0.550). Subgroup analysis by ethnicity further showed that VDR gene ApaI polymorphism was not associated with risk of breast cancer in both Asians and Caucasians. These data from the meta-analysis indicate that VDR gene ApaI polymorphism is not associated with breast cancer susceptibility.


VDR Breast cancer Meta-analysis 


Conflicts of interest



  1. 1.
    Patani N, Martin LA, Dowsett M. Biomarkers for the clinical management of breast cancer: international perspective. Int J Cancer. 2013;133:1–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Stevens KN, Vachon CM, Couch FJ. Genetic susceptibility to triple-negative breast cancer. Cancer Res. 2013;73:2025–30.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Barcellos-Hoff MH. Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer? Clin Cancer Res. 2013;19:541–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Jiao Z, Li D. Lack of association between mhtfr glu429ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies. Tumour Biol. 2013;34:1225–33.CrossRefPubMedGoogle Scholar
  5. 5.
    Cline J. Calcium and vitamin D metabolism, deficiency, and excess. Top Companion Anim Med. 2012;27:159–64.CrossRefPubMedGoogle Scholar
  6. 6.
    Geng S, Zhou S, Bi Z, Glowacki J. Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells. Metabolism. 2013;62:768–77.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL. Plasma vitamin D levels, menopause, and risk of breast cancer: dose–response meta-analysis of prospective studies. Med (Baltimore). 2013;92:123–31.CrossRefGoogle Scholar
  8. 8.
    van der Rhee H, Coebergh JW, de Vries E. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer. 2013;49:1422–36.CrossRefPubMedGoogle Scholar
  9. 9.
    Yang L, Ma J, Zhang X, Fan Y, Wang L. Protective role of the vitamin D receptor. Cell Immunol. 2012;279:160–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Duplancic D, Cesarik M, Poljak NK, Radman M, Kovacic V, Radic J, et al. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection. Clin Interv Aging. 2013;8:149–56.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, et al. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol. 2013;129:173–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Huang J, Yang J, Wang H, Xiong T, Zhang H, Ma Y, et al. The association between the poly(a) polymorphism in the VDR gene and cancer risk: a meta-analysis. Tumour Biol. 2013;34:1833–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Azad AK, Bairati I, Qiu X, Huang H, Cheng D, Liu G, et al. Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer. 2013;132:2520–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999;83:723–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, Lin SY, et al. Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat. 2002;74:1–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics. 2004;14:239–45.CrossRefPubMedGoogle Scholar
  17. 17.
    McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case–control study. Breast Cancer Res. 2007;9:R9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, Manjeshwar S, et al. Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J Am Coll Surg. 2012;215:652–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X, et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One. 2013;8:e57967.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  21. 21.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMedGoogle Scholar
  22. 22.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRefGoogle Scholar
  24. 24.
    Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Cui J, Shen K, Shen Z, Jiang F, Shen F. Relationship of vitamin D receptor polymorphism with breast cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18:286–8.PubMedGoogle Scholar
  27. 27.
    Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in North Indians. Cancer Detect Prev. 2009;32:386–94.CrossRefPubMedGoogle Scholar
  28. 28.
    Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev. 2011;20:1708–17.CrossRefPubMedGoogle Scholar
  29. 29.
    Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case–control study. Cancer Epidemiol Biomarkers Prev. 2012;21:1856–67.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Huang H, Zhou J, Zeng Q. Secondary lymphoedema after breast cancer surgery: a survival analysis. Int J Nurs Pract. 2012;18:589–94.CrossRefPubMedGoogle Scholar
  31. 31.
    Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170–80.CrossRefPubMedGoogle Scholar
  32. 32.
    Tang C, Chen N, Wu M, Yuan H, Du Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;117:391–9.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of Breast Surgery, Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations